{"transactions":[{"id":4613281,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-09T20:13:27.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":1590,"price":90,"value":143100.0,"ownership":{"direct":false,"nature":"By Spouse's Roth IRA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026."}],"balance_after":1590,"source":{"system":"sec-edgar","filing":"0001842190-26-000011","document":"wk-form4_1788984804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1842190/000184219026000011/wk-form4_1788984804.xml","form_type":"4"}},{"id":4613280,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-09T20:13:27.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":1590,"price":85,"value":135150.0,"ownership":{"direct":false,"nature":"By Spouse's Roth IRA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026."}],"balance_after":3180,"source":{"system":"sec-edgar","filing":"0001842190-26-000011","document":"wk-form4_1788984804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842190/000184219026000011/wk-form4_1788984804.xml","form_type":"4"}},{"id":4613279,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-09T20:13:27.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":5386,"price":90,"value":484740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026."}],"balance_after":2547,"source":{"system":"sec-edgar","filing":"0001842190-26-000011","document":"wk-form4_1788984804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842190/000184219026000011/wk-form4_1788984804.xml","form_type":"4"}},{"id":4613278,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-09T20:13:27.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":5387,"price":85,"value":457895.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026."}],"balance_after":7933,"source":{"system":"sec-edgar","filing":"0001842190-26-000011","document":"wk-form4_1788984804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842190/000184219026000011/wk-form4_1788984804.xml","form_type":"4"}},{"id":2420,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-03T20:29:51.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":1590,"price":80,"value":127200.0,"ownership":{"direct":false,"nature":"By Spouse's Roth IRA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026."}],"balance_after":4770,"source":{"system":"sec-edgar","filing":"0001842190-26-000009","document":"wk-form4_1788467389.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842190/000184219026000009/wk-form4_1788467389.xml","form_type":"4"}},{"id":2419,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-03T20:29:51.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":5387,"price":80,"value":430960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026."}],"balance_after":13320,"source":{"system":"sec-edgar","filing":"0001842190-26-000009","document":"wk-form4_1788467389.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842190/000184219026000009/wk-form4_1788467389.xml","form_type":"4"}},{"id":2418,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-03T20:29:51.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":4601,"price":73.86,"value":339829.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026."}],"balance_after":18707,"source":{"system":"sec-edgar","filing":"0001842190-26-000009","document":"wk-form4_1788467389.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842190/000184219026000009/wk-form4_1788467389.xml","form_type":"4"}},{"id":833577,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-19T23:04:04.000Z","date":"2026-03-19","kind":"sale","planned":false,"acquired":false,"shares":390,"price":67,"value":26130.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":23308,"source":{"system":"sec-edgar","filing":"0001842190-26-000007","document":"wk-form4_1773961442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000184219026000007/wk-form4_1773961442.xml","form_type":"4"}},{"id":833576,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-19T23:04:04.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":379,"price":68.71,"value":26041.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":23698,"source":{"system":"sec-edgar","filing":"0001842190-26-000007","document":"wk-form4_1773961442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000184219026000007/wk-form4_1773961442.xml","form_type":"4"}},{"id":833575,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-19T23:04:04.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":375,"price":69.42,"value":26032.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":24077,"source":{"system":"sec-edgar","filing":"0001842190-26-000007","document":"wk-form4_1773961442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000184219026000007/wk-form4_1773961442.xml","form_type":"4"}},{"id":838195,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:20:11.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":2511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service."}],"balance_after":7534,"derivative":{"underlying":"Common Stock","underlying_shares":2511},"source":{"system":"sec-edgar","filing":"0001842190-26-000005","document":"wk-form4_1773778809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000184219026000005/wk-form4_1773778809.xml","form_type":"4"}},{"id":838194,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:20:11.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":2511,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."}],"balance_after":24452,"source":{"system":"sec-edgar","filing":"0001842190-26-000005","document":"wk-form4_1773778809.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000184219026000005/wk-form4_1773778809.xml","form_type":"4"}},{"id":853665,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-09T20:06:27.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":17161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service."}],"balance_after":17161,"derivative":{"underlying":"Common Stock","underlying_shares":17161},"source":{"system":"sec-edgar","filing":"0001842190-26-000003","document":"wk-form4_1773086785.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000184219026000003/wk-form4_1773086785.xml","form_type":"4"}},{"id":853664,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-09T20:06:27.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":27310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 5, 2027, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service."}],"balance_after":27310,"derivative":{"exercise_price":74.9,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":27310},"source":{"system":"sec-edgar","filing":"0001842190-26-000003","document":"wk-form4_1773086785.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000184219026000003/wk-form4_1773086785.xml","form_type":"4"}},{"id":965190,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-17T21:07:14.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":6819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on November 4, 2024 in connection with the Reporting Person's appointment as Chief Medical Officer. 25% of the RSUs will vest on December 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on November 4, 2024 in connection with the Reporting Person's appointment as Chief Medical Officer. 25% of the RSUs will vest on December 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."}],"balance_after":20459,"derivative":{"underlying":"Common Stock","underlying_shares":6819},"source":{"system":"sec-edgar","filing":"0001842190-25-000003","document":"wk-form4_1766005632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000184219025000003/wk-form4_1766005632.xml","form_type":"4"}},{"id":965189,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-17T21:07:14.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":2078,"price":79.5,"value":165201.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":21941,"source":{"system":"sec-edgar","filing":"0001842190-25-000003","document":"wk-form4_1766005632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000184219025000003/wk-form4_1766005632.xml","form_type":"4"}},{"id":965188,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-17T21:07:14.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":6819,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the date of the Reporting Person's last report, 9,506 shares previously owned by the Reporting Person's Spouse's Roth IRA were transferred to the Reporting Person's self-directed IRA and are now directly owned."}],"balance_after":24019,"source":{"system":"sec-edgar","filing":"0001842190-25-000003","document":"wk-form4_1766005632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000184219025000003/wk-form4_1766005632.xml","form_type":"4"}},{"id":1105710,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2025-06-20T21:20:04.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":9708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders."}],"balance_after":9708,"derivative":{"exercise_price":16.85,"exercise_date":"2026-06-18","expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":9708},"source":{"system":"sec-edgar","filing":"0000950170-25-088590","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017025088590/ownership.xml","form_type":"4"}},{"id":1105709,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-20T21:20:04.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":5341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders."}],"balance_after":5341,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5341},"source":{"system":"sec-edgar","filing":"0000950170-25-088590","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017025088590/ownership.xml","form_type":"4"}},{"id":1108105,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-17T20:07:05.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":false,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-25-000097","document":"wk-form4_1750190816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000097/wk-form4_1750190816.xml","form_type":"4"}},{"id":1108104,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-17T20:07:05.000Z","date":"2025-06-16","kind":"sale","planned":false,"acquired":false,"shares":1006,"price":41.08,"value":41326.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":7694,"source":{"system":"sec-edgar","filing":"0001819790-25-000097","document":"wk-form4_1750190816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000097/wk-form4_1750190816.xml","form_type":"4"}},{"id":1108103,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-17T20:07:05.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":true,"shares":3350,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":8700,"source":{"system":"sec-edgar","filing":"0001819790-25-000097","document":"wk-form4_1750190816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000097/wk-form4_1750190816.xml","form_type":"4"}},{"id":1217574,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-07T21:17:18.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":10045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service."}],"balance_after":10045,"derivative":{"underlying":"Common Stock","underlying_shares":10045},"source":{"system":"sec-edgar","filing":"0001819790-25-000021","document":"wk-form4_1741382232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000021/wk-form4_1741382232.xml","form_type":"4"}},{"id":1217573,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-07T21:17:18.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":15314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option  shares shall vest on March 5, 2026, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service."}],"balance_after":15314,"derivative":{"exercise_price":44.54,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":15314},"source":{"system":"sec-edgar","filing":"0001819790-25-000021","document":"wk-form4_1741382232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000021/wk-form4_1741382232.xml","form_type":"4"}},{"id":1374335,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-11-06T21:40:29.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":27278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's appointment as Chief Medical Officer as disclosed in the Form 8-K dated November 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's appointment as Chief Medical Officer as disclosed in the Form 8-K dated November 5, 2024."}],"balance_after":27278,"derivative":{"underlying":"Common Stock","underlying_shares":27278},"source":{"system":"sec-edgar","filing":"0001819790-24-000121","document":"wk-form4_1730929222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000121/wk-form4_1730929222.xml","form_type":"4"}},{"id":1374334,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-06T21:40:29.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":41074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted in connection with the Reporting Person's appointment as Chief Medical Officer as disclosed in the Form 8-K dated November 5, 2024."}],"balance_after":41074,"derivative":{"exercise_price":46.21,"expiration_date":"2034-11-03","underlying":"Common Stock","underlying_shares":41074},"source":{"system":"sec-edgar","filing":"0001819790-24-000121","document":"wk-form4_1730929222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000121/wk-form4_1730929222.xml","form_type":"4"}},{"id":1469602,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-25T22:24:12.000Z","date":"2024-06-24","kind":"exercise","planned":false,"acquired":false,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-24-000100","document":"wk-form4_1719354246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000100/wk-form4_1719354246.xml","form_type":"4"}},{"id":1469601,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-25T22:24:12.000Z","date":"2024-06-24","kind":"exercise","planned":false,"acquired":true,"shares":3350,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":5350,"source":{"system":"sec-edgar","filing":"0001819790-24-000100","document":"wk-form4_1719354246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000100/wk-form4_1719354246.xml","form_type":"4"}},{"id":1471453,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-06-24T21:01:56.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term.  These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders."}],"balance_after":4010,"derivative":{"exercise_price":40.11,"exercise_date":"2025-06-20","expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":4010},"source":{"system":"sec-edgar","filing":"0000950170-24-076855","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017024076855/ownership.xml","form_type":"4"}},{"id":1471452,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T21:01:56.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":2244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term.  These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders."}],"balance_after":5099,"source":{"system":"sec-edgar","filing":"0000950170-24-076855","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017024076855/ownership.xml","form_type":"4"}},{"id":1479224,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-14T21:33:48.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":3350,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-24-000077","document":"wk-form4_1718400820.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000077/wk-form4_1718400820.xml","form_type":"4"}},{"id":1479223,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T21:33:48.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":5000,"derivative":{"exercise_price":33.14,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001819790-24-000077","document":"wk-form4_1718400820.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000077/wk-form4_1718400820.xml","form_type":"4"}},{"id":1666684,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-30T21:31:48.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted in connection with certain consulting services being provided by the Reporting Person. The option will vest in full on January 30, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":10000,"derivative":{"exercise_price":26.25,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001819790-24-000008","document":"wk-form4_1706650295.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000008/wk-form4_1706650295.xml","form_type":"4"}},{"id":1775132,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-22T23:18:22.000Z","date":"2023-09-21","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":40,"value":100000.0,"ownership":{"direct":true},"balance_after":2855,"source":{"system":"sec-edgar","filing":"0001209191-23-050429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919123050429/doc4.xml","form_type":"4"}},{"id":1803762,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T22:02:59.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":9506,"price":16.8,"value":159700.8,"ownership":{"direct":false,"nature":"By Spouse's Roth IRA"},"balance_after":15866,"source":{"system":"sec-edgar","filing":"0001819790-23-000073","document":"wk-form4_1692309770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000073/wk-form4_1692309770.xml","form_type":"4"}},{"id":1844318,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-26T21:49:15.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":3350,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-23-000056","document":"wk-form4_1687816146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000056/wk-form4_1687816146.xml","form_type":"4"}},{"id":1844317,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T21:49:15.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":5000,"derivative":{"exercise_price":17.99,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001819790-23-000056","document":"wk-form4_1687816146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000056/wk-form4_1687816146.xml","form_type":"4"}},{"id":1847970,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-21T22:14:50.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001819790-23-000042","document":"wk-form4_1687385681.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000042/wk-form4_1687385681.xml","form_type":"4"}},{"id":1847969,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T22:14:50.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001819790-23-000042","document":"wk-form4_1687385681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000042/wk-form4_1687385681.xml","form_type":"4"}},{"id":1853547,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-06-17T00:34:14.000Z","date":"2023-06-15","kind":"exercise","planned":false,"acquired":true,"shares":6256,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on the earlier of June 15, 2024 or the Corporation's 2024 Annual Shareholders Meeting, subject to her continued service through the vesting date."}],"balance_after":6256,"derivative":{"exercise_price":52.67,"exercise_date":"2024-06-15","expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":6256},"source":{"system":"sec-edgar","filing":"0001209191-23-038168","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919123038168/doc4.xml","form_type":"4"}},{"id":2157483,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T20:24:45.000Z","date":"2022-09-14","kind":"purchase","acquired":true,"shares":6360,"price":16.29,"value":103604.4,"ownership":{"direct":false,"nature":"By Spouse's Roth IRA"},"balance_after":6360,"source":{"system":"sec-edgar","filing":"0001628280-22-025078","document":"wf-form4_166335986585757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000162828022025078/wf-form4_166335986585757.xml","form_type":"4"}},{"id":2157482,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T20:24:45.000Z","date":"2022-09-14","kind":"purchase","acquired":true,"shares":12040,"price":16.03,"value":193001.2,"ownership":{"direct":false,"nature":"By 401(k) Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.94 to $16.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12040,"source":{"system":"sec-edgar","filing":"0001628280-22-025078","document":"wf-form4_166335986585757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000162828022025078/wf-form4_166335986585757.xml","form_type":"4"}},{"id":2217433,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-01T16:23:15.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":2000,"derivative":{"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001628280-22-018343","document":"wf-form4_165669257959779.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000162828022018343/wf-form4_165669257959779.xml","form_type":"4"}},{"id":2217432,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-01T16:23:15.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":7000,"derivative":{"exercise_price":12.89,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001628280-22-018343","document":"wf-form4_165669257959779.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000162828022018343/wf-form4_165669257959779.xml","form_type":"4"}},{"id":2229097,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2022-06-17T22:41:20.000Z","date":"2022-06-16","kind":"exercise","acquired":true,"shares":5765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to her continued service through the vesting date."}],"balance_after":5765,"derivative":{"exercise_price":61.1,"exercise_date":"2023-06-16","expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":5765},"source":{"system":"sec-edgar","filing":"0001209191-22-038107","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919122038107/doc4.xml","form_type":"4"}},{"id":2229096,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T22:41:20.000Z","date":"2022-06-16","kind":"exercise","acquired":true,"shares":355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock."}],"balance_after":355,"source":{"system":"sec-edgar","filing":"0001209191-22-038107","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919122038107/doc4.xml","form_type":"4"}},{"id":2449900,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T02:10:56.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest in 3 annual installments beginning on December 31, 2022, subject to the Reporting Person's continuous service."}],"balance_after":20000,"derivative":{"exercise_price":22.5,"expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-001245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919122001245/doc4.xml","form_type":"4"}},{"id":2655337,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2021-06-25T21:57:41.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on the earlier of June 24, 2022 or the Corporation's 2022 Annual Shareholders Meeting."}],"balance_after":1703,"derivative":{"exercise_price":154.96,"exercise_date":"2022-06-24","expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":1703},"source":{"system":"sec-edgar","filing":"0001209191-21-043365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121043365/doc4.xml","form_type":"4"}},{"id":2896866,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":1837,"kind":"person","name":"Lin Elizabeth Yeu","position":1,"cik":"0001842190","reported_name":"Lin Elizabeth Yeu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2021-01-26T22:29:43.000Z","date":"2021-01-21","kind":"grant","acquired":true,"shares":1367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on the earlier of July 30, 2021 or the Corporation's 2021 Annual Shareholders Meeting."}],"balance_after":1367,"derivative":{"exercise_price":89.67,"exercise_date":"2021-07-30","expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":1367},"source":{"system":"sec-edgar","filing":"0001209191-21-005475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121005475/doc4.xml","form_type":"4"}}]}